The p53 Tumor Suppressor Gene in Ductal Carcinoma in Situ of the Breast
- 1 January 2000
- journal article
- editorial
- Published by Elsevier in The American Journal of Pathology
- Vol. 156 (1) , 5-6
- https://doi.org/10.1016/s0002-9440(10)64698-6
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- p53 Mutations and Expression in Breast Carcinoma in SituThe American Journal of Pathology, 2000
- Ductal Carcinoma in Situ — The Focus for Prevention, Screening, and Breast Conservation in Breast CancerNew England Journal of Medicine, 1999
- Prognostic and predictive value of p53 and p21 in breast cancerBreast Cancer Research and Treatment, 1998
- Ductal Carcinoma In Situ of the Breast: a New ModelJNCI Journal of the National Cancer Institute, 1997
- Incidence of and Treatment for Ductal Carcinoma In Situ of the BreastJAMA, 1996
- p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data.1994
- p53 Mutations and c‐erbB‐2 Amplification in Intraductal and Invasive Breast Carcinomas of High Histologic GradeJapanese Journal of Cancer Research, 1993
- Maintenance of p53 alterations throughout breast cancer progression.1991
- Intraductal CarcinomaPublished by American Medical Association (AMA) ,1978
- Intraductal carcinoma. Long-term follow-up after treatment by biopsy aloneJAMA, 1978